AutoGenomics issued European patent for Human papillomavirus

Download PDF Copy

Editorial Checklist

Reviewed

Jun 19 2008

NewsGuard 100/100 Score

AutoGenomics has announced that it has been issued a key European patent for Human papillomavirus.

Patent No.1 499 749 B1, "Human papillomavirus Detection with DNA Microarray," claims to be a method for detecting the presence of HPV using a microarray.

"This patent is the result of our collaboration with Dr. Erik Thunnissen, a prominent clinician and opinion leader in the field of Human papillomavirus," said Mr. Fareed Kureshy, President and CEO of AutoGenomics.

He further said that "with increasing demands for alternative technologies to meet the evolving need for genotyping we are excited that we can offer an automated solution that can significantly enhance workflow efficiency in the laboratory".

Source:

http://www.autogenomics.com/

Posted in: Medical Patent News

Tags: DNA, Genotyping, Human Papillomavirus (HPV), Laboratory, Microarray

Comments (0)

Download PDF Copy

Suggested Reading

Researchers develop decision tree to help clinicians predict genetic diagnoses in neurodevelopmental cases

Researchers develop decision tree to help clinicians predict genetic diagnoses in neurodevelopmental cases

Study reveals genetic divergence and drug resistance mechanisms in two critical superbugs

Study reveals genetic divergence and drug resistance mechanisms in two critical superbugs

Measles and rubella vaccine delivered via microarray patch shows promising results

Measles and rubella vaccine delivered via microarray patch shows promising results

Arrayjet’s ArrayPlex platform selected by Immunome for use in its discovery of targeted cancer therapies

Arrayjet’s ArrayPlex platform selected by Immunome for use in its discovery of targeted cancer therapies

Needle-free vaccine patch can protect people from deadly Zika virus

Needle-free vaccine patch can protect people from deadly Zika virus

New study shows how brain glucose affects fungal disease treatment

New study shows how brain glucose affects fungal disease treatment

Innovative HiTIP-seq method advances epigenetic research in pediatric brain tumors

Innovative HiTIP-seq method advances epigenetic research in pediatric brain tumors

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Genetic test streamlines diagnosis of rare developmental disorders